HUP9902880A3 - Steroid bisphosphonates, process for their production and medicaments containing the same - Google Patents

Steroid bisphosphonates, process for their production and medicaments containing the same

Info

Publication number
HUP9902880A3
HUP9902880A3 HU9902880A HUP9902880A HUP9902880A3 HU P9902880 A3 HUP9902880 A3 HU P9902880A3 HU 9902880 A HU9902880 A HU 9902880A HU P9902880 A HUP9902880 A HU P9902880A HU P9902880 A3 HUP9902880 A3 HU P9902880A3
Authority
HU
Hungary
Prior art keywords
bisphosphonates
steroid
production
same
medicaments containing
Prior art date
Application number
HU9902880A
Other languages
English (en)
Original Assignee
Univ Liverpool
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Liverpool filed Critical Univ Liverpool
Publication of HUP9902880A2 publication Critical patent/HUP9902880A2/hu
Publication of HUP9902880A3 publication Critical patent/HUP9902880A3/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J51/00Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/548Phosphates or phosphonates, e.g. bone-seeking

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HU9902880A 1996-06-28 1997-06-26 Steroid bisphosphonates, process for their production and medicaments containing the same HUP9902880A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9613722.9A GB9613722D0 (en) 1996-06-28 1996-06-28 Chemical compounds
PCT/GB1997/001748 WO1998000438A1 (en) 1996-06-28 1997-06-26 Steroid bisphosphonates

Publications (2)

Publication Number Publication Date
HUP9902880A2 HUP9902880A2 (hu) 2000-03-28
HUP9902880A3 true HUP9902880A3 (en) 2001-09-28

Family

ID=10796129

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9902880A HUP9902880A3 (en) 1996-06-28 1997-06-26 Steroid bisphosphonates, process for their production and medicaments containing the same

Country Status (23)

Country Link
US (1) US6140518A (hu)
EP (1) EP0912598A1 (hu)
JP (1) JP2000513372A (hu)
KR (1) KR20000022262A (hu)
CN (1) CN1226253A (hu)
AP (1) AP9801431A0 (hu)
AU (1) AU3350697A (hu)
BG (1) BG103123A (hu)
BR (1) BR9710074A (hu)
CA (1) CA2259309A1 (hu)
CZ (1) CZ432398A3 (hu)
EE (1) EE9800454A (hu)
GB (1) GB9613722D0 (hu)
HU (1) HUP9902880A3 (hu)
IL (1) IL127781A0 (hu)
IS (1) IS4931A (hu)
NO (1) NO986112L (hu)
PL (1) PL330781A1 (hu)
SK (1) SK175198A3 (hu)
TR (1) TR199900490T2 (hu)
WO (1) WO1998000438A1 (hu)
YU (1) YU59898A (hu)
ZA (1) ZA975749B (hu)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8586781B2 (en) 1998-04-02 2013-11-19 Mbc Pharma, Inc. Bone targeted therapeutics and methods of making and using the same
US6896871B2 (en) 1998-04-02 2005-05-24 Mbc Research, Inc. Biphosphonate conjugates and methods of making and using the same
US7598246B2 (en) * 1998-04-02 2009-10-06 Mbc Pharma, Inc. Bisphosphonate conjugates and methods of making and using the same
ATE451382T1 (de) 1999-01-20 2009-12-15 Takara Bio Inc 4-substituierte-3,6-anhydro-galaktosederivate und ihre pharmazeutische verwendung
AU781068B2 (en) * 1999-08-19 2005-05-05 Sydney Children's Hospitals Network (Randwick and Westmead) (incorporating The Royal Alexandra Hospital for Children), The Drug for treating fractures
AUPQ232599A0 (en) * 1999-08-19 1999-09-09 Royal Alexandra Hospital For Children, The Drug for treating fractures
US6436386B1 (en) 2000-11-14 2002-08-20 Shearwater Corporation Hydroxyapatite-targeting poly (ethylene glycol) and related polymers
US7829074B2 (en) 2001-10-18 2010-11-09 Nektar Therapeutics Hydroxypatite-targeting poly(ethylene glycol) and related polymers
EP1383510B1 (en) * 2001-04-10 2012-10-17 MBC Pharma, Inc. Bisphosphonate conjugates and methods of making and using the same
EA200401565A1 (ru) * 2002-05-24 2005-04-28 Неофарм, Инк. Способ получения кардиолипина или аналога кардиолипина (варианты), способ получения липосомы и композиция кардиолипина для лечения заболеваний (варианты)
JP2006518701A (ja) * 2002-05-24 2006-08-17 ネオファーム、インコーポレイティッド カルジオリピン組成物、その製造方法及び使用
US20050277611A1 (en) * 2002-10-16 2005-12-15 Neopharm, Inc. Cationic cardiolipin analoges and its use thereof
US20060078560A1 (en) * 2003-06-23 2006-04-13 Neopharm, Inc. Method of inducing apoptosis and inhibiting cardiolipin synthesis
FI20070244A0 (fi) 2007-03-23 2007-03-23 Metso Paper Inc Tela
CA2702945C (en) 2007-10-23 2016-08-23 Nektar Therapeutics Al, Corporation Hydroxyapatite-targeting multiarm polymers and conjugates made therefrom
CA2843885C (en) 2011-08-01 2020-03-10 Mbc Pharma, Inc. Vitamin b6 derivatives of nucleotides, acyclonucleotides and acyclonucleoside phosphonates
CN103945869A (zh) * 2011-08-31 2014-07-23 马林克罗特有限公司 使用h-膦酸酯-烯/-炔的氢膦酸酯化反应进行的靶向纳米颗粒的远程组装
US10660884B2 (en) 2015-11-02 2020-05-26 University Of Rochester Phosphonate-chloroquine conjugates and methods using same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4029499A1 (de) * 1990-09-18 1992-03-19 Boehringer Mannheim Gmbh Neue 17-(beta)-oestradiolderivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
EP0496520A1 (en) * 1991-01-22 1992-07-29 Merck & Co. Inc. Novel bone acting agents
FR2683527A1 (fr) * 1991-11-12 1993-05-14 Bretagne Occidentale Universit Prodrogues gem-bisphosphonates de sterouides derives de la cortisone.
JP3141053B2 (ja) * 1991-12-26 2001-03-05 アベンティス ファーマ株式会社 ビスホスホン酸誘導体
JP2746041B2 (ja) * 1992-02-14 1998-04-28 三菱化学株式会社 新規なステロイド誘導体

Also Published As

Publication number Publication date
AP9801431A0 (en) 1998-12-31
CZ432398A3 (cs) 1999-05-12
YU59898A (en) 1999-11-22
SK175198A3 (en) 1999-06-11
WO1998000438A1 (en) 1998-01-08
NO986112D0 (no) 1998-12-23
BG103123A (en) 1999-10-29
AU3350697A (en) 1998-01-21
IS4931A (is) 1998-12-22
KR20000022262A (ko) 2000-04-25
CN1226253A (zh) 1999-08-18
IL127781A0 (en) 1999-10-28
BR9710074A (pt) 2000-01-18
PL330781A1 (en) 1999-06-07
HUP9902880A2 (hu) 2000-03-28
ZA975749B (en) 1998-07-27
GB9613722D0 (en) 1996-08-28
NO986112L (no) 1999-02-23
CA2259309A1 (en) 1998-01-08
US6140518A (en) 2000-10-31
EE9800454A (et) 1999-06-15
JP2000513372A (ja) 2000-10-10
TR199900490T2 (xx) 1999-05-21
EP0912598A1 (en) 1999-05-06

Similar Documents

Publication Publication Date Title
HUP0004422A3 (en) 2-aryl-8-oxohydropurine derivatives, process for producing them, medicaments containing the same
HUP9702534A3 (en) Propiophenone derivatives, process for preparing them and medicaments containing the said compounds
AU4299796A (en) Composite material containing aerogel, process for manufacturing the same and the use thereof
HUP9802565A3 (en) N-benzyl-dioxothiazolidinylmethyl-benzamide derivatives, pharmaceutical compositions containing them and process for producing the same
EP0871209A4 (en) PLATELET CLEANING SOLUTION AND METHOD FOR PRODUCING THE SAME
IL131298A0 (en) A pharmaceutical composition and a process for producing the same
HUP0002718A3 (en) Piperazine derivatives, process for their preparation and medicaments containing the same
HUP9902880A3 (en) Steroid bisphosphonates, process for their production and medicaments containing the same
EP0960568A4 (en) MANNOSE-BASED FOOD AND PROCESS FOR PRODUCING THE SAME
EP0785205A4 (en) 2-SILYLOXYTETRAHYDROTHIENOPYRIDINE, ITS SALT, AND ITS PRODUCTION METHOD
HUP0100927A3 (en) Antitumor substituted indene-derivatives, process for their preparation, medicaments containing them and their use
HUP9801766A3 (en) 6-carboxamido dihydropyran derivatives, process for producing them and medicaments containing the same
AU6926496A (en) New cyclic guanidines, process for preparing the same and medicaments
HUP9901376A3 (en) 1-methylcarbapenem derivatives, their use, production thereof and medicaments containing the same
HUP9903902A3 (en) Bromotiacumicin compounds, process for producing them and medicaments containing the same
AU4278897A (en) 10,13,15-Trioxatricyclo(9.2.1.1.9.6)-Pentadecanone derivatives, method for the production thereof and medicaments containing these compounds
HUP9600665A2 (en) Substituted benzothienylpiperazines, their use as medicaments, and processes for their preparation
HUP9802316A3 (en) Didepsipeptide-based endoparasiticides, new didepsipeptides and process for preparing the same
HUP9904603A3 (en) Vitamin d3 derivatives, medicaments containing the same and process for production thereof
AU6124599A (en) 1,5-benzodiazepine compounds, process for producing the same, and medicine
HUP9701316A3 (en) Substituted indanylideneacetylguanidines, process for their preparation, and medicaments and diagnostics containing them
IL125004A0 (en) Process for the preparation of 9,11 beta-epoxide steroids
HUP9904592A3 (en) 1,2-dithiolane-derivatives, process for their production and medicaments containing them
HUP9903696A3 (en) 5-naphthalen-1-yl-1,3-dioxane derivatives, medicaments containing the same and process for producing them
HUT76806A (en) Technetium-sulphonamide complexes, their use, pharmaceutical agents containing them, and process for producing the complexes and agents